New Releases from NCBI BookshelfToripalimab (Loqtorzi): Therapeutic area: Recurrent or metastatic nasopharyngeal carcinoma: Reimbursement Review [Internet].Toripalimab (Loqtorzi): Therapeutic area: Recurrent or metastatic nasopharyngeal carcinoma: Reimbursement Review [Internet].
Nasopharyngeal carcinoma (NPC) is a rare malignancy of the nasopharynx with distinct features; it has strong geographic and ethnic variation […]
